Compare $NGNE vs $PBYI | Chartloom

Compare

$NGNE vs $PBYI

Neurogene Inc · Puma Biotechnology Inc

NGNE

Neurogene Inc

PBYI

Puma Biotechnology Inc

Compare $NGNE vs $PBYI

Comparing Neurogene Inc and Puma Biotechnology Inc

NGNENeurogene Inc

PBYIPuma Biotechnology Inc

NGNENeurogene Inc

Market cap

$521M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

31.0%

52W performance

2.2%

FCF yield

-16.8%

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NGNE

PBYI

Detailed metrics comparison

NGNE

Neurogene Inc

PBYI

Puma Biotechnology Inc

Market Cap

NGNE$521M

PBYI$524M

Enterprise Value

NGNE$409M

PBYI$487M

Price

NGNE$26.40

PBYI$10.29

P/E Ratio

NGNEN/A

PBYI20.26x

P/S Ratio

NGNE0.00x

PBYI2.26x

EV/Sales

NGNE0.00x

PBYI2.11x

EV/EBITDA

NGNE0.00x

PBYI10.51x

P/B Ratio

NGNE2.36x

PBYI3.54x

P/FCF Ratio

NGNEN/A

PBYI12.75x

EV/FCF

NGNE-4.66x

PBYI11.86x

PEG Ratio

NGNEN/A

PBYIN/A

Forward P/E (NTM)

NGNEN/A

PBYIN/A

Forward P/S (NTM)

NGNEN/A

PBYIN/A

Revenue (TTM)

NGNE$0

PBYI$231M

Revenue Growth (YoY)

NGNEN/A

PBYI-2.9%

Forward Rev Growth

NGNE127.3%

PBYI-1.4%

Gross Margin (TTM)

NGNE0.0%

PBYI74.8%

Operating Margin (TTM)

NGNE0.0%

PBYI13.2%

EBITDA Margin (TTM)

NGNE0.0%

PBYI17.7%

Net Margin (TTM)

NGNE0.0%

PBYI11.6%

FCF Margin (TTM)

NGNEN/A

PBYI17.8%

Net Income (TTM)

NGNE$-46M

PBYI$27M

FCF (TTM)

NGNE$-88M

PBYI$41M

EPS (TTM)

NGNE$0.00

PBYI$0.51

ROE (TTM)

NGNE-2527.0%

PBYI20.8%

ROA (TTM)

NGNE-2325.0%

PBYI13.3%

ROIC (TTM)

NGNE-2527.0%

PBYI18.4%

Cash

NGNE$112M

PBYI$37M

Debt

NGNE$8K

PBYI$0

Net Cash/Debt

NGNE$112M

PBYI$37M

Current Ratio (TTM)

NGNE10.64x

PBYI2.91x

Quick Ratio (TTM)

NGNE10.53x

PBYI2.57x

Debt/Equity (TTM)

NGNE0.00x

PBYI0.17x

Debt/Assets (TTM)

NGNE0.0%

PBYI0.0%

Interest Coverage (TTM)

NGNEN/A

PBYIN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

PBYI0.00x

Beta

NGNE1.71

PBYI1.36

52W Performance

NGNE2.2%

PBYI96.7%

YTD Performance

NGNE31.0%

PBYI78.3%

% from 52W High

NGNE-39.5%

PBYI-0.8%

% from 52W Low

NGNE65.7%

PBYI124.7%

Asset Turnover (TTM)

NGNE0.00x

PBYI1.15x

FCF Yield (TTM)

NGNE-16.8%

PBYI7.8%

Earnings Yield (TTM)

NGNE-8.8%

PBYI5.1%

Dividend Yield (TTM)

NGNEN/A

PBYIN/A

Rule of 40

NGNE0.0

PBYI14.9

EV/GP/RG

NGNEN/A

PBYIN/A

Ticker research

View NGNE research View PBYI research

Metric	NGNE Neurogene Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$521M	$524M
Enterprise Value	$409M	$487M
Price	$26.40	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	0.00x	2.26x
EV/Sales	0.00x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	2.36x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-4.66x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	127.3%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	0.0%	17.7%
Net Margin (TTM)	0.0%	11.6%
FCF Margin (TTM)	N/A	17.8%
Net Income (TTM)	$-46M	$27M
FCF (TTM)	$-88M	$41M
EPS (TTM)	$0.00	$0.51
ROE (TTM)	-2527.0%	20.8%
ROA (TTM)	-2325.0%	13.3%
ROIC (TTM)	-2527.0%	18.4%
Financial Health
Cash	$112M	$37M
Debt	$8K	$0
Net Cash/Debt	$112M	$37M
Current Ratio (TTM)	10.64x	2.91x
Quick Ratio (TTM)	10.53x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	1.36
52W Performance	2.2%	96.7%
YTD Performance	31.0%	78.3%
% from 52W High	-39.5%	-0.8%
% from 52W Low	65.7%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-16.8%	7.8%
Earnings Yield (TTM)	-8.8%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	14.9
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View PBYI research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

NGNE

0.00x

PBYI

2.26x

EV/FCF

NGNE

-4.66x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

PBYI

-2.9%

Forward Revenue Growth

NGNE

127.3%

PBYI

-1.4%

Profitability & performance

Gross Margin

PBYI

74.8%

NGNE

0.0%

ROE

PBYI

20.8%

NGNE

-2527.0%

FCF Yield %

PBYI

7.8%

NGNE

-16.8%

52-Week Performance

PBYI

96.7%

NGNE

2.2%

Detailed metrics comparison

NGNE

Neurogene Inc

PBYI

Puma Biotechnology Inc

Market Cap

NGNE$521M

PBYI$524M

Enterprise Value

NGNE$409M

PBYI$487M

Price

NGNE$26.40

PBYI$10.29

P/E Ratio

NGNEN/A

PBYI20.26x

P/S Ratio

NGNE0.00x

PBYI2.26x

EV/Sales

NGNE0.00x

PBYI2.11x

EV/EBITDA

NGNE0.00x

PBYI10.51x

P/B Ratio

NGNE2.36x

PBYI3.54x

P/FCF Ratio

NGNEN/A

PBYI12.75x

EV/FCF

NGNE-4.66x

PBYI11.86x

PEG Ratio

NGNEN/A

PBYIN/A

Forward P/E (NTM)

NGNEN/A

PBYIN/A

Forward P/S (NTM)

NGNEN/A

PBYIN/A

Revenue (TTM)

NGNE$0

PBYI$231M

Revenue Growth (YoY)

NGNEN/A

PBYI-2.9%

Forward Rev Growth

NGNE127.3%

PBYI-1.4%

Gross Margin (TTM)

NGNE0.0%

PBYI74.8%

Operating Margin (TTM)

NGNE0.0%

PBYI13.2%

EBITDA Margin (TTM)

NGNE0.0%

PBYI17.7%

Net Margin (TTM)

NGNE0.0%

PBYI11.6%

FCF Margin (TTM)

NGNEN/A

PBYI17.8%

Net Income (TTM)

NGNE$-46M

PBYI$27M

FCF (TTM)

NGNE$-88M

PBYI$41M

EPS (TTM)

NGNE$0.00

PBYI$0.51

ROE (TTM)

NGNE-2527.0%

PBYI20.8%

ROA (TTM)

NGNE-2325.0%

PBYI13.3%

ROIC (TTM)

NGNE-2527.0%

PBYI18.4%

Cash

NGNE$112M

PBYI$37M

Debt

NGNE$8K

PBYI$0

Net Cash/Debt

NGNE$112M

PBYI$37M

Current Ratio (TTM)

NGNE10.64x

PBYI2.91x

Quick Ratio (TTM)

NGNE10.53x

PBYI2.57x

Debt/Equity (TTM)

NGNE0.00x

PBYI0.17x

Debt/Assets (TTM)

NGNE0.0%

PBYI0.0%

Interest Coverage (TTM)

NGNEN/A

PBYIN/A

Net Debt/EBITDA (TTM)

NGNE0.00x

PBYI0.00x

Beta

NGNE1.71

PBYI1.36

52W Performance

NGNE2.2%

PBYI96.7%

YTD Performance

NGNE31.0%

PBYI78.3%

% from 52W High

NGNE-39.5%

PBYI-0.8%

% from 52W Low

NGNE65.7%

PBYI124.7%

Asset Turnover (TTM)

NGNE0.00x

PBYI1.15x

FCF Yield (TTM)

NGNE-16.8%

PBYI7.8%

Earnings Yield (TTM)

NGNE-8.8%

PBYI5.1%

Dividend Yield (TTM)

NGNEN/A

PBYIN/A

Rule of 40

NGNE0.0

PBYI14.9

EV/GP/RG

NGNEN/A

PBYIN/A

Ticker research

View NGNE research View PBYI research

Metric	NGNE Neurogene Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$521M	$524M
Enterprise Value	$409M	$487M
Price	$26.40	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	0.00x	2.26x
EV/Sales	0.00x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	2.36x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-4.66x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	127.3%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	0.0%	17.7%
Net Margin (TTM)	0.0%	11.6%
FCF Margin (TTM)	N/A	17.8%
Net Income (TTM)	$-46M	$27M
FCF (TTM)	$-88M	$41M
EPS (TTM)	$0.00	$0.51
ROE (TTM)	-2527.0%	20.8%
ROA (TTM)	-2325.0%	13.3%
ROIC (TTM)	-2527.0%	18.4%
Financial Health
Cash	$112M	$37M
Debt	$8K	$0
Net Cash/Debt	$112M	$37M
Current Ratio (TTM)	10.64x	2.91x
Quick Ratio (TTM)	10.53x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	1.36
52W Performance	2.2%	96.7%
YTD Performance	31.0%	78.3%
% from 52W High	-39.5%	-0.8%
% from 52W Low	65.7%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.15x
FCF Yield (TTM)	-16.8%	7.8%
Earnings Yield (TTM)	-8.8%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	14.9
EV/GP/RG	N/A	N/A
Ticker research	View NGNE research	View PBYI research